Literature DB >> 30532902

Supravalvular thrombus after pulmonary artery banding and fontan procedure evaluated by multidetector-row computed tomography.

Akira Kurata1, Takashi Higaki2, Eiichi Yamamoto2, Fumiaki Shikata3, Toru Okamura3, Mitsugi Nagashima3, Tomoyuki Kido1, Teruhito Kido1, Masao Miyagawa1, Teruhito Mochizuki1.   

Abstract

The mechanisms responsible for thromboembolic events in children with congenital heart disease have not yet been fully elucidated. Furthermore, establishment of long-term anticoagulation therapy in Fontan patients remains controversial. Here, we report the case of a 9-year-old boy who presented with hemiparesis due to a thromboembolic stroke; the boy had previously undergone staged pulmonary artery banding and Fontan procedure. Cardiac multidetector-row computed tomography (MDCT) clearly showed the supravalvular thrombus at the roofed (blind) pulmonary valve and circulatory stasis, which could be considered a possible source of the thrombus. Follow-up CT examination showed that the thrombus disappeared, but the circulatory stasis remained. Therefore, because the risk of thrombus formation was not eliminated, anticoagulation therapy was continued for the patient. Our case indicates the possible application of cardiac MDCT for providing insight into the hemodynamic mechanisms responsible for the thromboembolic events in children with congenital heart disease.

Entities:  

Keywords:  Anticoagulation therapy; Congenital heart disease; Fontan procedure; Multidetector-row computed tomography; Thrombosis

Year:  2011        PMID: 30532902      PMCID: PMC6265222          DOI: 10.1016/j.jccase.2011.09.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  9 in total

1.  Incidence, outcome, and risk factors for stroke after the Fontan procedure.

Authors:  David S Chun; Marcus S Schamberger; Theresa Flaspohler; Mark W Turrentine; John W Brown; Anne G Farrell; Donald A Girod
Journal:  Am J Cardiol       Date:  2004-01-01       Impact factor: 2.778

2.  Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.

Authors:  Y F Cheung; George W Chay; Clement S W Chiu; L C Cheng
Journal:  Int J Cardiol       Date:  2005-07-20       Impact factor: 4.164

Review 3.  Thromboembolic problems after the Fontan operation.

Authors:  Paul Monagle; Tom R Karl
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2002

Review 4.  Thromboembolism and the role of anticoagulation in the Fontan patient.

Authors:  M L Jacobs; K K Pourmoghadam
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

5.  Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis).

Authors:  Renate Kaulitz; Gerhard Ziemer; Ralf Rauch; Monika Girisch; Harald Bertram; Armin Wessel; Michael Hofbeck
Journal:  J Thorac Cardiovasc Surg       Date:  2005-03       Impact factor: 5.209

6.  Beyond the pulmonary arteries: alternative diagnoses in children with MDCT pulmonary angiography negative for pulmonary embolism.

Authors:  Edward Y Lee; Supika Kritsaneepaiboon; David Zurakowski; Claudia Martinez Rios Arellano; Keith J Strauss; Phillip M Boiselle
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

7.  Embolic stroke after ligation of the pulmonary artery in patients with functional single ventricle.

Authors:  J A Oski; C E Canter; T L Spray; J S Kan; D E Cameron; A M Murphy
Journal:  Am Heart J       Date:  1996-10       Impact factor: 4.749

8.  Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure.

Authors:  C B Mahnke; G J Boyle; J E Janosky; R D Siewers; F A Pigula
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

9.  MDCT evaluation of congenital mitral-aortic intervalvular fibrosa aneurysm: implications for the aetiology and differential diagnosis.

Authors:  I-Chen Tsai; Yun-Ching Fu; Pao-Chun Lin; Ming-Chih Lin; Sheng-Ling Jan
Journal:  Pediatr Radiol       Date:  2008-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.